A case report published in BMC Neurology describes a 56-year-old man who died after developing autoimmune encephalitis characterized by the simultaneous presence of anti-NMDA and anti-GAD65 antibodies. The case report, authored by Tulay Guler, highlights the diagnostic complexities associated with overlapping antibody profiles in this condition. While autoimmune encephalitis typically presents with a wide range of neuropsychiatric symptoms, the coexistence of multiple antibodies remains an area of incomplete clinical understanding. The report suggests that such overlapping antibodies may expand the phenotypic spectrum of the disease, making it difficult for clinicians to attribute specific symptoms to a single disorder. In some cases, these complex antibody profiles are associated with more difficult disease courses and poorer patient outcomes.
The patient’s clinical journey began with initial episodes of shouting and muscle contractions, which were initially misdiagnosed as psychogenic non-epileptic seizures. As the condition progressed, the patient developed generalized tonic-clonic seizures, necessitating admission to the intensive care unit. Upon admission, cerebrospinal fluid analysis was performed to investigate the underlying cause of the seizures. The analysis confirmed the presence of both anti-NMDA and anti-GAD65 antibodies in the patient’s cerebrospinal fluid.
Despite the confirmation of the diagnosis, the patient’s clinical response to treatment was limited. Medical management included pulse methylprednisolone therapy, followed by plasmapheresis. However, these interventions did not lead to an improvement in the patient’s neurological status.
The authors of the case report emphasize the significant diagnostic challenges presented by overlapping antibody profiles in autoimmune encephalitis. The report suggests that the coexistence of these antibodies may serve as a predictor of a poorer prognosis.
Although reports of overlapping antibodies in autoimmune encephalitis are increasing, their precise clinical significance remains incompletely understood. The authors conclude that early recognition and management are critical for patients presenting with symptoms suggestive of autoimmune encephalitis.
Subject of Research: Clinical presentation and outcome of autoimmune encephalitis with overlapping anti-NMDA and anti-GAD65 antibodies
Article Title: Coexisting anti-NMDA and anti-GAD65 antibodies in a patient with autoimmune encephalitis: a case report
Article References: Guler, T. (2026). Coexisting anti-NMDA and anti-GAD65 antibodies in a patient with autoimmune encephalitis: a case report. BMC Neurology. https://doi.org/10.1186/s12883-026-05559-0
Image Credits: AI Generated
DOI: 10.1186/s12883-026-05559-0
Keywords: autoimmune encephalitis, anti-NMDA antibodies, anti-GAD65 antibodies, neurology, case report, cerebrospinal fluid, seizures, diagnostic challenges, prognosis, Coexisting, anti-NMDA, anti-GAD65
News Source: Ophelia Keating. (November 7, 2026). Overlapping Antibodies Linked to Fatal Autoimmune Encephalitis. Scienmag.



